As mentioned earlier, we have also tested the effects of TGF-β inhibitors on the growth of A549 tumors in mice (González-Gualda et al., 2022), where tumor volume was significantly restored but not completely to baseline levels. The gene discussed is TGFB1; the disease is neoplasm.